Press Releases IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Market Closed - Nasdaq Stockholm Other stock markets 11:29:43 2024-05-31 am EDT			5-day change	1st Jan Change
15.6 ^SEK	-0.95%		-0.95%	+108.00%

May. 27	Sweden’s IRLAB Therapeutics Names New CEO	MT
May. 27	IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

IRLAB appoints Kristina Torfgard as new CEO	May. 28	AQ
IRLAB presents at Redeye Growth Day 30 May	May. 28	AQ
IRLAB appoints Kristina Torfgård as new CEO	May. 27	AQ
IRLAB strengthens its liquidity by drawing SEK 25 million on a previously secured loan facility	May. 23	AQ
Report from the Annual General Meeting 2024 of IRLAB Therapeutics AB	May. 22	AQ
IRLAB has administered the first dose in a Phase I clinical trial with the drug candidate IRL757	May. 22	AQ
IRLAB broadcasts the annual general meeting live	May. 22	AQ
IRLAB presents at ABGSC Investor Days	May. 21	AQ
IRLAB publishes interim report for the period January-March 2024	May. 08	AQ
IRLAB Enters a Development Collaboration for IRL757 as a Novel Treatment for Apathy	May. 07	AQ
IRLAB has received approval from the Swedish Medical Products Agency to conduct a Phase I study of the drug candidate IRL757	May. 06	AQ
IRLAB: Invitation to the interim report for Q1 2024 presentation and webcast	May. 06	AQ
IRLAB publishes Annual Report for 2023	Apr. 29	AQ
IRLAB to present at Redeye Investor Forum	Apr. 16	AQ
IRLAB receives minutes from End-of-Phase 2 meeting confirming alignment with the FDA on the Phase III program for mesdopetam	Mar. 25	AQ
IRLAB receives minutes from End-of-Phase 2 meeting confirming alignment with the FDA on the Phase III program for mesdopetam	Mar. 22	AQ
IRLAB Therapeutics : mesdopetam displays antipsychotic properties in an advanced model of Parkinson's disease psychosis	Mar. 19	PU
IRLAB’s mesdopetam displays antipsychotic properties in an advanced model of Parkinson’s disease psychosis	Mar. 19	AQ
IRLAB to present at Life Science-dagen in Gothenburg and have a fireside chat with ABG	Feb. 29	AQ
IRLAB to present at the Bayes@Lund 2024 Conference in Lund, Sweden on March 7	Feb. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Press Releases

Filters